SpyGlass Pharma, Inc. Common Stock (SGP) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−12.6x

Market Cap

$967.98M

MomentumView details →

1D Return

−0.17%

YTD Return

—

RSI (14)

69.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−12.6x

Market Cap

$967.98M

RSI (14)

69.7

MomentumView details →

1D Return

−0.17%

YTD Return

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−24.12%

ROA (TTM)

−23.03%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$0.59

EPS Surprise

−14.69%

Beats (12Q)

0/12

Next Q EPS Est

−$0.62

Avg Surprise (4Q)

−315.99%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

25.06x

Quick Ratio

25.06x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−56.05M

Op. CF (TTM)

−46.56M

Next earningsNov 5, 2026 →

Latest newsMore news →

No recent news for SGP.

Similar companies

Adlai Nortye Ltd.ANL Sunho Biologics, Inc.02898.HK Ardelyx, Inc.ARDX Candel Therapeutics, Inc.CADL Wave Life Sciences Ltd.WVE Design Therapeutics, Inc.DSGN Find similar companies →

Latest newsMore news →

No recent news for SGP.